Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sandra Martinez-Canales"'
Autor:
Juan Carlos Montero, Sandra Martinez-Canales, Verónica Corrales-Sánchez, Ana Alcaraz-Sanabria, Eva María Galán-Moya, Atanasio Pandiella, Cristina Nieto-Jiménez, Miriam Nuncia-Cantarero, Miguel Burgos, Alberto Ocaña
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 9034, p 9034 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
International Journal of Molecular Sciences
Volume 21
Issue 23
Digital.CSIC. Repositorio Institucional del CSIC
instname
International Journal of Molecular Sciences
Volume 21
Issue 23
© 2020 by the authors.
Basal-like breast cancer is an incurable disease with limited therapeutic options, mainly due to the frequent development of anti-cancer drug resistance. Therefore, identification of druggable targets to improve current t
Basal-like breast cancer is an incurable disease with limited therapeutic options, mainly due to the frequent development of anti-cancer drug resistance. Therefore, identification of druggable targets to improve current t
Autor:
Alberto Ocaña, Eitan Amir, Atanasio Pandiella, Eva María Galán-Moya, Raquel Páez, Sandra Martinez-Canales, Balázs Győrffy, Miriam Nuncia-Cantarero, Miguel López de Rodas
Publikováno v:
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Cancer Medicine
Consejo Superior de Investigaciones Científicas (CSIC)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Cancer Medicine
© 2018 The Authors.
Although early stage ovarian cancer is in most cases a curable disease, some patients relapse even with appropriate adjuvant treatment. Therefore, the identification of patient and tumor characteristics to better stratify ri
Although early stage ovarian cancer is in most cases a curable disease, some patients relapse even with appropriate adjuvant treatment. Therefore, the identification of patient and tumor characteristics to better stratify ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9e9d8102bd517467ccc9c8a201a4740
Autor:
Eva María Galán-Moya, Francisco Cifuentes, Leticia Serrano-Oviedo, Eitan Amir, Atanasio Pandiella, Alberto Ocaña, Balázs Győrffy, Sandra Martinez-Canales, Miguel López De Rodas Gregorio
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0175128 (2017)
Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS ONE, Vol 12, Iss 5, p e0175128 (2017)
Digital.CSIC. Repositorio Institucional del CSIC
instname
[Background]: Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable outcome. [Methods]: Gene expr
Autor:
Sandra Martínez‐Canales, Miguel López de Rodas, Miriam Nuncia‐Cantarero, Raquel Páez, Eitan Amir, Balázs Győrffy, Atanasio Pandiella, Eva María Galán‐Moya, Alberto Ocaña
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1896-1907 (2018)
Abstract Although early stage ovarian cancer is in most cases a curable disease, some patients relapse even with appropriate adjuvant treatment. Therefore, the identification of patient and tumor characteristics to better stratify risk and guide rati
Externí odkaz:
https://doaj.org/article/1808a90537044f01a46f0842ed995026
Autor:
Sandra Martínez-Canales, Francisco Cifuentes, Miguel López De Rodas Gregorio, Leticia Serrano-Oviedo, Eva María Galán-Moya, Eitan Amir, Atanasio Pandiella, Balázs Győrffy, Alberto Ocaña
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175128 (2017)
BACKGROUND:Most patients with early stage triple negative breast cancer (TNBC) receive adjuvant chemotherapy. Activation of the immune system is associated with tumor response and may help identify TNBC with favorable outcome. METHODS:Gene expression
Externí odkaz:
https://doaj.org/article/1b582cb409bb425da74040e54c8825f7